Yonsei Cancer Center's Lung Cancer Center team has earned the prestigious title of Asia's best multidisciplinary team during the World Conference on Lung Cancer 2023 (WCLC 2023), held in Singapore from last Saturday to Tuesday. This achievement marks a significant milestone, as it is the first time
Novelty Nobility, a biotech specializing in antibody drug discovery, said on Monday that it launched the PREXISE-D Order-to-Discovery Solution (OTD Solution), a fully humanized mouse antibody discovery service for pharmaceutical companies in Korea. Novelty Nobility's PREXISE-D is a fit-for-purpose a
SK bioscience said on Friday that it signed a memorandum of understanding (MOU) with the Serbian government and Frontier Biopharma to develop the vaccine manufacturing environment in Serbia.Consequently, SK bioscience and Frontier Biopharma also agreed to sign a contract within the year to establish
After two days of active discussions on the up-to-date knowledge of cancer research and patient care, the 5th Korean Society of Medical Oncology’s International Conference (KSMO 2023) closed its doors on Friday. It was KSMO’s first return to full strength in four years since the Covid-19 pandemic wi
CHA Bundang Hospital said it provided medical care to a 2-year-old Bangladeshi child, surnamed Mohammed, with cholesteatoma and epilepsy.Cholesteatoma is an abnormal, noncancerous growth that forms behind the eardrum or from the eardrum. In children patients, the disease can grow in size and damage
After receiving preliminary listing approval from the Korea Exchange, Curocell has maintained that it will proceed with an initial public offering (IPO) this year.The Korea Exchange's Kosdaq market headquarters approved the preliminary listing review of Curocell on Thursday. That comes about four mo
After Roche Korea decided to withdraw its Parkinson's syndrome cure, Madopar, Korean patients called for measures to ensure the public’s trust in the quality of generic drugs.They also stressed the need to strengthen the standards for bioequivalence testing, which confirms the equivalence of generic
CG Bio said Friday that it recently organized the "Meet the Korean Masters of Endoscopic Spine Surgery," an educational session on spine endoscopic surgery for overseas medical professionals.CG Bio and other companies have formed a consortium to provide the training session under the auspices of the
Recent data indicates that phentermine, often referred to as a weight loss pill, has been the most reported drug for side effects among obesity treatments prescribed in Korea.Such data was confirmed through a joint study conducted by Kyung Hee University's School of Pharmacy and Ajou University's Sc
AstraZeneca Korea's lung cancer drug Tagrisso (osimertinib) has passed the Drug Reimbursement Evaluation Committee, taking a step closer to expanded coverage for first-line lung cancer treatment.The Health Insurance Review and Assessment Service (HIRA) held the 10th committee meeting on Thursday and
Kai Health, a fertility AI company, said on Friday that it obtained European medical device certification for its embryo analysis AI solution, Eve.Accordingly, the CE certification allows Kai Health to sell Eve to countries in the European Union and other countries that acknowledge the CE certificat
A report has unveiled that over the past three years (2020-2023), one out of 10 doctors in Korea self-prescribed narcotic drugs. Remarkably, one in every four of these professionals has consistently self-prescribed narcotic drugs annually during that period. According to a Ministry of Food and Drug
Representatives from the Asia-Pacific drew urgency to the need to come to a consensus on the appropriate standards and criteria to evaluate obesity to avoid confusion and lead to improved obesity outcomes in Asia.The Korean Society for the Study of Obesity (KSSO) hosted the 2023 International Congre
Aptose Biosciences, the U.S. partner of Hanmi Pharm in the development of HM43239, an acute myeloid leukemia (AML) treatment candidate containing tuspetinib, has announced the successful completion of a $3 million investment from Hanmi in the form of common shares in the company.According to Aptose,
Korea United Pharm said it has signed a five-year supply and distribution agreement with MCQ, a Thai-based pharmaceutical company specializing in drug distribution, for Levotics CR Tab., a mucoactive drug.Levotics CR Tab. is an incrementally modified drug (IMD) that improves compliance and convenien
A survey shows that an information gap on Covid-19 vaccines is emerging between infectious disease specialists and general practitioners who directly administer vaccines to patients.The Korean Association of Medical Journalists (KAM) released the "Public and Expert Perception Survey on Covid-19 Vacc
Some Korean biopharmaceutical companies, including LG Chem, Hanmi Pharmaceutical, and Daewoong Bio, are considering introducing the continuous manufacturing (CM) process, attracting the industry’s attention.Unlike the existing “batch-type” production, continuous manufacturing (CM) is a method of man
The 16th Annual Meeting of the Korean Society of Medical Oncology (KSMO) and the 5th International Conference (KSMO 2023), kicked off at the Grand Walkerhill Seoul on Thursday to break down barriers to improve cancer treatment, discuss the future of medical oncology, and exchange new and diverse ide
ABL Bio said Thursday it signed a non-exclusive license agreement to use Synaffix's antibody-drug conjugate (ADC) platform technology to develop up to three ADCs using its antibodies. The agreement includes an upfront payment, tiered milestones, and royalties in exchange for non-exclusive rights. St
Eight out of 10 people with knee osteoarthritis are over 60. As the number of older adults increases, that of patients with “knee osteoarthritis,” a degenerative disease, is also steadily increasing. Accordingly, related medical expenses are also rising.On Thursday, the National Health Insurance Ser